Validation of the Infectious Diseases Society of America/American Thoratic Society Minor Criteria for Intensive Care Unit Admission in Community-Acquired Pneumonia Patients Without Major Criteria or Contraindications to Intensive Care Unit Care

被引:98
作者
Chalmers, James D. [1 ,2 ]
Taylor, Joanne K. [2 ]
Mandal, Pallavi [2 ]
Choudhury, Gourab [1 ]
Singanayagam, Aran [3 ]
Akram, Ahsan R. [1 ]
Hill, Adam T. [1 ,2 ]
机构
[1] Royal Infirm Edinburgh NHS Trust, Dept Resp Med, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland
[3] St Marys Hosp, London, England
基金
英国医学研究理事会;
关键词
SEVERITY ASSESSMENT; PREDICTION RULE; GUIDELINES; METAANALYSIS; STATISTICS; MANAGEMENT; MORTALITY; OUTCOMES; THERAPY; ADULTS;
D O I
10.1093/cid/cir463
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The 2007 Infectious Disease Society of America/American Thoracic Society (IDSA/ATS) guidelines for community-acquired pneumonia (CAP) recommended new criteria to guide admission to the intensive care unit (ICU) for patients with this condition. Although the major criteria (requirement for mechanical ventilation or septic shock requiring vasopressor support) are well established, the value of the minor criteria alone have not been fully validated. Methods. We performed a prospective observational study of consecutive adult patients with CAP admitted to NHS Lothian (Scotland, United Kingdom). Patients meeting the IDSA/ATS major criteria on admission were excluded, along with patients not suitable for ICU care owing to advanced directives or major comorbid illnesses. Performance characteristics for the IDSA/ATS minor criteria were calculated and compared with those for alternative scoring systems identified in the literature. Two definitions of severe CAP were used as primary end points: ICU admission, and subsequent requirement for mechanical ventilation or vasopressor support (MV/VS); 30-day mortality was a secondary outcome. Results. The study included 1062 patients with CAP potentially eligible for ICU admission. Each of the 9 minor criteria was associated with increased risk of MV/VS and 30-day mortality in univariate analysis. Two hundred seven patients had >= 3 minor criteria (19.5%). The IDSA/ATS 2007 criteria had an area under the receiver operating characteristic curve of 0.85 (0.82-0.88) for prediction of MV/VS, 0.85 (0.82-0.88) for prediction of ICU admission, and 0.78 (0.74-0.82) for prediction of 30-day mortality. The IDSA/ATS 2007 criteria were at least equivalent to more established scoring systems for prediction of MV/VS and ICU admission and equivalent to alternative scoring systems for predicting 30-day mortality in this patient population. Conclusions. In a population of patients with CAP without contraindications to ICU care, the IDSA/ATS minor criteria predict subsequent requirement for MV/VS, ICU admission, and 30-day mortality.
引用
收藏
页码:503 / 511
页数:9
相关论文
共 35 条
  • [1] Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia
    Brown, Samuel M.
    Jones, Barbara E.
    Jephson, Al R.
    Dean, Nathan C.
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (12) : 3010 - 3016
  • [2] A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia
    Buising, KL
    Thursky, KA
    Black, JF
    MacGregor, L
    Street, AC
    Kennedy, MP
    Brown, GV
    [J]. THORAX, 2006, 61 (05) : 419 - 424
  • [3] Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia
    Chalmers, J. D.
    Singanayagam, A.
    Hill, A. T.
    [J]. THORAX, 2008, 63 (08) : 698 - 702
  • [4] Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
    Chalmers, J. D.
    Akram, A. R.
    Hill, A. T.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (04) : 858 - 864
  • [5] Safety and efficacy of CURB65-guided antibiotic therapy in community-acquired pneumonia
    Chalmers, James D.
    Singanayagam, Aran
    Akram, Ahsan R.
    Choudhury, Gourab
    Mandal, Pallavi
    Hill, Adam T.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (02) : 416 - 423
  • [6] Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis
    Chalmers, James D.
    Singanayagam, Aran
    Akram, Ahsan R.
    Mandal, Pallavi
    Short, Philip M.
    Choudhury, Gourab
    Wood, Victoria
    Hill, Adam T.
    [J]. THORAX, 2010, 65 (10) : 878 - 883
  • [7] ICU admission and severity assessment in community-acquired pneumonia
    Chalmers, James D.
    [J]. CRITICAL CARE, 2009, 13 (03)
  • [8] Chalmers JD, 2011, INTENSIVE CARE MED
  • [9] SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia
    Charles, Patrick G. P.
    Wolfe, Rory
    Whitby, Michael
    Fine, Michael J.
    Fuller, Andrew J.
    Stirling, Robert
    Wright, Alistair A.
    Ramirez, Julio A.
    Christiansen, Keryn J.
    Waterer, Grant W.
    Pierce, Robert J.
    Armstrong, John G.
    Korman, Tony M.
    Holmes, Peter
    Obrosky, D. Scott
    Peyrani, Paula
    Johnson, Barbara
    Hooy, Michelle
    Grayson, M. Lindsay
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : 375 - 384
  • [10] Rocket Science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) Guidelines for Severe Community-Acquired Pneumonia
    Charles, Patrick G. P.
    Davis, Joshua S.
    Grayson, M. Lindsay
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1796 - 1796